Download PDF
CC BY-NC-ND 4.0 · South Asian J Cancer 2014; 03(01): 094-095
DOI: 10.4103/2278-330x.126580
Letter to Editor

Authors' Reply

Sudeep Gupta
Departments of Medical Oncology, Parel, Mumbai, Maharashtra, India
,
Rajendra A. Kerkar
1Surgical Oncology, Parel, Mumbai, Maharashtra, India
,
Rajesh Dikshit
Epidemiology, Tata Memorial Hospital, Parel, Mumbai, Maharashtra, India
,
Rajendra A. Badwe
Departments of Medical Oncology, Parel, Mumbai, Maharashtra, India
› Author Affiliations
› Further Information
  PDF Download Permissions and Reprints


Publication History

Article published online:
31 December 2020

© 2014. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/.)

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

 

  • References

  • 1 Palefsky J. HPV vaccination in India.South Asian J Cancer 2014;3:96-7.
  • 2 Gupta S, Kerkar RA, Dikshit R, Badwe RA. Is human papillomavirus vaccination likely to be a useful strategy in India? South Asian J Cancer 2013;2:193-7.
  • 3 FUTURE II Study Group. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. N Engl J Med 2007;356:1915-27.
  • 4 Vidal AC, Smith JS, Iversen E, Valea F, Bentley R, Gradison M, et al. HPV genotype distribution and cervical intraepithelial neoplasia in African-American and white women living in the southeastern United States. AACR-FCPR 2013; Abstract B11, PR01.
  • 5 Mahmud SM, Kliewer EV, Lambert P, Bozat-Emre S, Demers AA. Effectiveness of the Quadrivalent Human Papillomavirus Vaccine Against Cervical Dysplasia in Manitoba, Canada. J Clin Oncol 2014;32:1-7.
  • 6 Dhillon PK, Yeole BB, Dikshit R, Kurkure AP, Bray F. Trends in breast, ovarian and cervical cancer incidence in Mumbai, India over a 30-year period, 1976-2005: An age-period-cohort analysis. Br J Cancer 2011;105:723-30.
  • 7 Available from: http://www.globocan.iarc.fr/Pages/fact_sheets_ population.aspx. [Last accessed 2013 Dec 30].
  • 8 Wright TC Jr, Stoler MH, Behrens CM, Apple R, Derion T, Wright TL. The ATHENA human papillomavirus study: Design, methods, and baseline results. Am J Obstet Gynecol 2012;206:46.e1-4611.
  • 9 Souayah N, Michas-Martin PA, Nasar A, Krivitskaya N, Yacoub HA, Khan H, et al. Guillain-Barré syndrome after Gardasil vaccination: Data from Vaccine Adverse Event Reporting System 2006-2009. Vaccine 2011;29:886-9.
  • 10 Slade BA, Leidel L, Vellozzi C, Woo EJ, Hua W, Sutherland A, et al. Postlicensure safety surveillance for quadrivalent human papillomavirus recombinant vaccine. JAMA 2009;302:750-7.
  • 11 Shastri SS, Mittra I, Mishra G, Gupta S, Dikshit R, Badwe RA. Effect of visual inspection with acetic acid (VIA) screening by primary health workers on cervical cancer mortality: A cluster randomized controlled trial in Mumbai, India. J Clin Oncol. 2013;31(suppl; abstr 2).